Although women in the Yoplait group lost an average of 11 pounds (5 kg) over the 12-week study period, there was no significant difference in weight loss between the two groups (11)
These compounds are not designed, labeled, or intended for human use, injection, dosing, or ingestion
Other lawsuits target supplements that purport to address the side effects of taking a treatment
The medication makes it easier to maintain a deficit naturally, but overeating (especially processed foods) can still result in weight gain or plateau
Injectable semaglutide and tirzepatide created the current market base, but oral GLP-1s, dual agonists, triple agonists, generics, biosimilars and longer-interval dosing could reshape procurement and partnership strategies